Abstract
Background: Kinesin family member 26B (KIF26B) plays a key role in the development and progression of many human cancers. However, the role and underlying mechanisms of KIF26B in breast cancer cells remain unknown. Materials and methods: In this study, we inhibited the expression of KIF26B in MDA-MB-231 and MCF-7 cells using lentivirus-delivered shRNA. Results: Lentivirus-mediated KIF26B knockdown significantly suppressed cell proliferation, colony formation, migration, and invasion. Furthermore, cell cycle analyses revealed that the percentage of cells in the G0/G1 phase was significantly increased in KIF26B knockdown cells. Moreover, the knockdown of KIF26B significantly promoted cell apoptosis via the upregulation of cleaved caspase-3 and Bax. Conclusion: Our data indicate that KIF26B plays a pivotal role in tumor growth and metastasis in breast cancer cells and may be a potential therapeutic target for treating breast cancer.
Author supplied keywords
Cite
CITATION STYLE
Gu, S., Liang, H., Qi, D., Liyan Mao, Mao, G., Qian, L., & Zhang, S. (2018). Knockdown of KIF26B inhibits breast cancer cell proliferation, migration, and invasion. OncoTargets and Therapy, 11, 3195–3203. https://doi.org/10.2147/OTT.S163346
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.